CANVASC WEBINAR SERIES

Reducing Corticosteroid Exposure in
ANCA Vasculitis: EGPA

After attending this event, participants will be better able to:

Appreciate the role of glucocorticosteroids in EGPA and the toxicity related to steroids
Consider the evidence of anti-IL5 biologics as steroid-sparing therapies in EGPA
Relate steroid sparing to eosinophil suppression
Compare the effects of steroids vs biologics on Vasculitic vs non-Vasculitic components of EGPA

Parameswaran Nair

MD, PhD, FRCP, FRCPC, FCAHS

Professor of Medicine

McMaster University

Nader A. Khalidi, MD, FRCPC

Professor of Medicine

McMaster University